IL90408A0 - Method for producing non-hyperglycosylated hepatitis b virus proteins - Google Patents

Method for producing non-hyperglycosylated hepatitis b virus proteins

Info

Publication number
IL90408A0
IL90408A0 IL90408A IL9040889A IL90408A0 IL 90408 A0 IL90408 A0 IL 90408A0 IL 90408 A IL90408 A IL 90408A IL 9040889 A IL9040889 A IL 9040889A IL 90408 A0 IL90408 A0 IL 90408A0
Authority
IL
Israel
Prior art keywords
hyperglycosylated
hepatitis
producing non
virus proteins
virus
Prior art date
Application number
IL90408A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL90408A0 publication Critical patent/IL90408A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5764—Hepatitis B surface antigen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IL90408A 1988-06-03 1989-05-25 Method for producing non-hyperglycosylated hepatitis b virus proteins IL90408A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20276488A 1988-06-03 1988-06-03

Publications (1)

Publication Number Publication Date
IL90408A0 true IL90408A0 (en) 1990-01-18

Family

ID=22751163

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90408A IL90408A0 (en) 1988-06-03 1989-05-25 Method for producing non-hyperglycosylated hepatitis b virus proteins

Country Status (11)

Country Link
EP (1) EP0344864A3 (da)
JP (1) JPH02150292A (da)
KR (1) KR900000091A (da)
AU (1) AU616976B2 (da)
DK (1) DK272189A (da)
FI (1) FI892683A (da)
IL (1) IL90408A0 (da)
NO (1) NO892269L (da)
NZ (1) NZ229260A (da)
PT (1) PT90690A (da)
ZA (1) ZA894182B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE207535T1 (de) * 1987-06-22 2001-11-15 Medeva Holdings Bv Hepatitis-b-oberflächenantigen enthaltendes peptid
CA2022108A1 (en) * 1989-07-31 1991-02-01 Cheryl A. Schulman Enhanced growth and expression of heterologous proteins in recombinant hosts containing mutations in cell wall and/or plasma membrane biosynthesis
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
JP3026029B2 (ja) * 1991-04-26 2000-03-27 財団法人阪大微生物病研究会 組換え水痘ウイルスとその作製法
CA2067003A1 (en) * 1991-04-29 1992-10-30 Peter J. Kniskern Hbsag escape mutant vaccine
IL101651A0 (en) * 1991-04-29 1992-12-30 Merck & Co Inc Hepatitis b virus surface proteins with reduced host carbohydrate content
IL101653A0 (en) * 1991-04-29 1992-12-30 Merck & Co Inc Multiple hepatitis b virus surface proteins which form particles
EP0533263A3 (en) * 1991-09-20 1994-06-08 Merck & Co Inc A multivalent hepatitis b virus vaccine
DE4301904A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh Hypoglycosylierte recombinante Glucoseoxidase
DE4301932A1 (de) * 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh Hefewirtsstämme mit Defekten in der N-Glycosylierung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU584580B2 (en) * 1982-09-08 1989-06-01 Smith Kline - Rit Hepatitis B virus vaccine
EP0401941A3 (en) * 1984-07-11 1991-04-17 Takeda Chemical Industries, Ltd. Hepatitis b virus surface antigen and production thereof
DE3537176C2 (de) * 1984-10-18 1994-06-09 Zymogenetics Inc Gewebeplasminogenaktivator und Verfahren zu seiner Herstellung
JPS61158798A (ja) * 1984-12-28 1986-07-18 Japan Found Cancer Res Ｂ型肝炎ウイルス表面抗原の製造法
WO1988006185A1 (en) * 1987-02-11 1988-08-25 Scripps Clinic And Research Foundation Retroviral expression vectors and methods for producing hbv antigens
AU619753B2 (en) * 1987-06-22 1992-02-06 Medeva Holdings B.V. Hepatitis b surface antigen vaccine

Also Published As

Publication number Publication date
FI892683A (fi) 1989-12-04
NZ229260A (en) 1994-02-25
DK272189A (da) 1989-12-04
PT90690A (pt) 1989-12-29
NO892269L (no) 1989-12-04
AU616976B2 (en) 1991-11-14
FI892683A0 (fi) 1989-06-01
EP0344864A2 (en) 1989-12-06
JPH02150292A (ja) 1990-06-08
KR900000091A (ko) 1990-01-30
NO892269D0 (no) 1989-06-02
EP0344864A3 (en) 1990-09-12
AU3597089A (en) 1989-12-07
ZA894182B (en) 1990-02-28
DK272189D0 (da) 1989-06-02

Similar Documents

Publication Publication Date Title
PH25249A (en) Method for producing hepatitis b virus proteins in yeast
HK38293A (en) Hepatitis c virus
GB2212511B (en) Hepatitis c virus
LTIP1793A (en) Method for detecting antibodies against hiv virus
GB8901469D0 (en) Proteins and method for their production
HUT51789A (en) Headlamp and method for producing same
HU894117D0 (en) Process for producing hirudine-like peptones
ZA894182B (en) Method for producing nonhyperglycosylated hepatitis b virus proteins
GR900100165A (en) Method for preparing sulfo-triazolo-diazepino-derivatives
EP0585549A3 (en) Method for producing ectoprotein of hepatitis c virus
HU893786D0 (en) Process for producing proteins and nucleinic acids
IL95585A0 (en) Method for activating protein c
HU905943D0 (en) Process for producing anti-coagulant and anti-helmintic proteins and their utilization
PL279105A1 (en) Method of obtaining the pre s down 2 protein of hepatitis b
HUT51670A (en) Process for producing modified proteins
GB9005900D0 (en) Process for purifying proteins
HUT55641A (en) Process for producing hantaan virus
EP0264118A3 (en) Novel method for preparing proteins
IL85893A0 (en) Method for stabilizing proteins
HUT49567A (en) Process for concentrating urea-solution
RO102743B1 (en) Sodium-bichromate producing method
GB8927844D0 (en) Process for producing non-structural protein of japanese encephalitis virus
AU1668788A (en) Method of vaccination for hepatitis b virus
GB2181434A (en) Hepatitis b virus vaccine and process for its preparation
IE891804L (en) Nonhyperglycosylated hepatitis b virus proteins